Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ADMA Biologics Inc, 3 years.
ADMA Biologics Inc
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | ADMA Biologics Inc | Open-market purchase | +6,400 | $7.91 | $50,624 |
| May 12, 2026 | ADMA Biologics Inc | Open-market purchase | +12,500 | $8.01 | $100,125 |
| May 11, 2026 | ADMA Biologics Inc | Open-market purchase | +12,500 | $8.01 | $100,125 |
| Feb 9, 2026 | ADMA Biologics Inc | Grant or award | +10,690 | — | — |
| Jun 9, 2025 | ADMA Biologics Inc | Option exercise | +10,000 | $5.00 | $50,000 |
| Jun 9, 2025 | ADMA Biologics Inc | Open-market sale | −10,000 | $21.31 | $213,100 |
| Feb 19, 2025 | ADMA Biologics Inc | Grant or award | +10,889 | — | — |
| Aug 29, 2024 | ADMA Biologics Inc | Option exercise | +118,861 | $3.66 | $435,031 |
| Aug 29, 2024 | ADMA Biologics Inc | Option exercise | +9,000 | $5.96 | $53,640 |
| Aug 29, 2024 | ADMA Biologics Inc | Option exercise | +9,000 | $10.80 | $97,200 |
| Aug 29, 2024 | ADMA Biologics Inc | Open-market sale | −136,861 | $17.27 | $2,363,589 |
| Feb 26, 2024 | ADMA Biologics Inc | Grant or award | +24,040 | — | — |
| Aug 30, 2023 | ADMA Biologics Inc | Open-market purchase | +130,000 | $3.71 | $482,300 |
| Mar 6, 2023 | ADMA Biologics Inc | Grant or award | +25,815 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.